Skip to content
PICO Portalanswers from OpenAlex

Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19

PaperCitations, authors & open-access status

Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 is a paper indexed in PICO Portal from OpenAlex.

How many citations does Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 have?

PICO Portalcitation count

Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 has 175 citations in the OpenAlex counts PICO Portal stores.

When was Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 published?

PICO Portalyear

Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 has 2020 year in the PICO Portal index.

What is the open-access status of Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19?

PICO Portaloa status

Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 has hybrid oa status in the PICO Portal index.

What is the DOI of Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19?

PICO Portaldoi

The DOI for Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 is on the source record.

What is the PMID of Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19?

PICO Portalpmid

The PMID for Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 is on the source record.

What is the OpenAlex record for Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19?

PICO Portalopenalex

The OpenAlex for Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19 is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial